Clinical Trials
HCC clinical trials currently enrolling patients. Bring the NCT number to your next oncology appointment to ask if you may be eligible.
NCT07811687Recruiting
Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function
Updated: Sep 10, 2026
View on ClinicalTrials.gov
NCT07814014Recruiting
Real-world Insight Into Systemic Therapies for HCC: Single-center Study
Updated: Sep 10, 2026
View on ClinicalTrials.gov
NCT07806292Recruiting
Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study
Updated: Sep 8, 2026
View on ClinicalTrials.gov
NCT07808164Recruiting
ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort
Updated: Sep 8, 2026
View on ClinicalTrials.gov
NCT07801287Recruiting
Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCC
Updated: Sep 3, 2026
View on ClinicalTrials.gov
NCT07799922Recruiting
IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus
Updated: Sep 2, 2026
View on ClinicalTrials.gov
NCT07795437Recruiting
GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma
Updated: Sep 2, 2026
View on ClinicalTrials.gov
NCT07714538Recruiting
Breath Research Narrow Validation for Gastrointestinal Cancer Detection
Updated: Sep 11, 2026
View on ClinicalTrials.gov
NCT07677774Recruiting
GPC3-Targeted PET/CT in Hepatocellular Carcinoma
Updated: Sep 10, 2026
View on ClinicalTrials.gov
NCT07650773Recruiting
CHARM Hepatocellular Carcinoma MEA Study
Updated: Sep 3, 2026
View on ClinicalTrials.gov
NCT07636148Recruiting
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
Updated: Sep 1, 2026
View on ClinicalTrials.gov
NCT07557251Recruiting
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
Updated: Aug 31, 2026
View on ClinicalTrials.gov
NCT07463248Recruiting
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
Updated: Sep 2, 2026
View on ClinicalTrials.gov
NCT07446257Recruiting
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
Updated: Sep 3, 2026
View on ClinicalTrials.gov
NCT07381660Recruiting
SBRT Versus Surgical Resection for Small HCC
Updated: Sep 1, 2026
View on ClinicalTrials.gov
NCT07284121Recruiting
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Updated: Sep 11, 2026
View on ClinicalTrials.gov
NCT07272083Recruiting
New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules
Updated: Sep 9, 2026
View on ClinicalTrials.gov
NCT07062055Recruiting
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Updated: Sep 4, 2026
View on ClinicalTrials.gov
NCT06999837Recruiting
[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.
Updated: Sep 3, 2026
View on ClinicalTrials.gov
NCT06995898Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Updated: Sep 2, 2026
View on ClinicalTrials.gov
NCT06921785Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Updated: Sep 3, 2026
View on ClinicalTrials.gov
NCT06811116Recruiting
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Updated: Sep 3, 2026
View on ClinicalTrials.gov
NCT06638502Recruiting
Safety of HRX215 in Patients After Minor and Major Liver Resection
Updated: Sep 1, 2026
View on ClinicalTrials.gov
NCT06621472Recruiting
Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery
Updated: Sep 1, 2026
View on ClinicalTrials.gov
NCT06563947Recruiting
Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy
Updated: Sep 10, 2026
View on ClinicalTrials.gov
NCT06526338Recruiting
Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
Updated: Sep 4, 2026
View on ClinicalTrials.gov
NCT06486454Recruiting
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Updated: Sep 11, 2026
View on ClinicalTrials.gov
NCT06427941Recruiting
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Updated: Sep 8, 2026
View on ClinicalTrials.gov
NCT06309485Recruiting
Phase 2 Study of WGI-0301 for Advanced HCC
Updated: Sep 11, 2026
View on ClinicalTrials.gov
NCT06294548Recruiting
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
Updated: Sep 1, 2026
View on ClinicalTrials.gov
NCT06252753Recruiting
Observational Study Protocol: LIVER-R
Updated: Sep 8, 2026
View on ClinicalTrials.gov
NCT06066138Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Updated: Sep 8, 2026
View on ClinicalTrials.gov
NCT05497531Recruiting
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Updated: Aug 31, 2026
View on ClinicalTrials.gov
NCT05304481Recruiting
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Updated: Sep 1, 2026
View on ClinicalTrials.gov
NCT04864054Recruiting
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Updated: Sep 10, 2026
View on ClinicalTrials.gov